GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncodesign Precision Medicine SA (XPAR:ALOPM) » Definitions » Issuance of Stock

Oncodesign Precision Medicine (XPAR:ALOPM) Issuance of Stock

: €0.00 Mil (TTM As of Jun. 2022)
View and export this data going back to 2022. Start your Free Trial

Oncodesign Precision Medicine's Issuance of Stock for the six months ended in Jun. 2022 was €0.00 Mil.

Oncodesign Precision Medicine's Issuance of Stock for the trailing twelve months (TTM) ended in Jun. 2022 was €0.00 Mil.


Oncodesign Precision Medicine Issuance of Stock Historical Data

The historical data trend for Oncodesign Precision Medicine's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncodesign Precision Medicine Annual Data
Trend Dec20 Dec21
Issuance of Stock
- -

Oncodesign Precision Medicine Semi-Annual Data
Dec20 Dec21 Jun22
Issuance of Stock - - -

Oncodesign Precision Medicine Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Issuance of Stock for the trailing twelve months (TTM) ended in Jun. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oncodesign Precision Medicine Issuance of Stock Related Terms

Thank you for viewing the detailed overview of Oncodesign Precision Medicine's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


Oncodesign Precision Medicine (XPAR:ALOPM) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
18 rue Jean Mazen, Dijon, FRA, 21000
Oncodesign Precision Medicine SA is a biopharmaceutical company specialised in precision medicine. Its mission is to provide patients with effective diagnostic and therapeutic solutions for resistant and metastatic cancers.

Oncodesign Precision Medicine (XPAR:ALOPM) Headlines

No Headlines